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Background and Aims: The prevalence of overweight and obesity consitutes a
global epidemic and it is growing around the world. Food and nutrition are essential
requirements for promoting health and protecting against non-communicable chronic
diseases, such as obesity and cardiovascular disease. Specific dietary components
may modulate inflammation and oxidative stress in obese individuals. The Dietary
Inflammatory Index (DII® ) was developed to characterize the anti- and pro-inflammatory
effects of individuals’ diet. Few studies have investigated the role of diet-associated
inflammation in adolescents with obesity. The present study aims to investigate the effects
of an interdisciplinary weight loss therapy on DII scores and cardiometabolic risk in obese
adolescents and possibles correlations.
Methods: A total of 45 volunteers (14–19 years old) were recruited and enrolled
for long-term interdisciplinary therapy including clinical, nutritional, psychological
counseling, and exercise training. Adolescents had access to videos about
health education weekly. Body composition and inflammatory and serum
profiles were evaluated at baseline and after intervention. The food intake was
obtained by 24-h food recall. Data was used to calculate energy-adjusted DII
(E-DII) scores. Negative scores indicate an anti-inflammatory diet and positive
scores indicates a pro-inflammatory diet. The sample was divided according
to whether individuals increased or decreased E-DII scores after therapy.
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Results: After therapy the body mass index (BMI), body weight, body fat, abdominal,
waist, neck, and hip circumferences decreased significantly. The mean of high-density
lipoprotein cholesterol (HDL-c) increased after the therapy. There was found an
improvement of inflammatory and cardiometabolic parameters. In exploratory analyses,
this occurred mainly when the EDII improved.
Conclusion: Long-term interdisciplinary therapy combined with a health education
website improved inflammatory serum markers in obese adolescents. Reduction in DII
scores was associated with reduction of cardiometabolic parameters, suggesting that
an anti-inflammatory diet may be an effective strategy to prevent and treat obesity and
related comorbidities.
Trial: http://www.ensaiosclinicos.gov.br/rg/RBR-6txv3v/, Register Number: RBR6txv3v
Keywords: inflammatory diet, cardiometabolic risk, interdisciplinary therapy, obesity, inflammation

INTRODUCTION

metabolic disorders, intestinal dysbiosis, Parkinson’s disease,
cancer, depression, and bone weakness (15–23).
The Dietary Inflammatory Index (DII R ) was created in 2009
to quantify the effect of diet on inflammatory potential, which
was further improved and validated by Shivappa et al. (24).
A literature review in 2010 encompassing 1,943 papers studied
the association between each of the six inflammatory markers
(Interleukin-1β, Interleukin-4, Interleukin-6, Interleukin-10,
Tumor Necrosis Factor-α, and C-reactive protein) and 45 food
parameters. Negative scores suggest that the meal or ingested
food may have anti-inflammatory effects, while positive values
indicate pro-inflammatory effects (24). Specifically, among South
American population, DII has been tested with colorectal
and prostate cancers in Argentina and multiple sclerosis and
metabolic syndrome in Brazil (25–27).
Previously, a pro-inflammatory diet has been validated
with inflammatory markers among adolescents and has been
shown to be associated with increased risk of childhood
obesity, cardiometabolic risk, depression, and stress levels
among adolescents (28–32). Accordingly, studies conducted
in adolescents have indicated that elevated intake of sugarsweetened soft drinks, refined grains, processed foods, and
low intake of vegetables and fiber may increase the incidence
of premenopausal breast cancer and cardiometabolic risks
(30, 33, 34).
Interesting, multi and interdisciplinary programs have been
conducted in adolescents to promote obesity management and
long-term weight loss therapies have been shown to produce
favorable changes in metabolic parameters and inflammation.
While the effects of exercise training are pretty well described,
it remains so far unclear how diet can influence obesity related
inflammatory markers, such as, adiponectin and leptin in
adolescents (11, 35–39).
This study was designed to investigate the effects of an
interdisciplinary therapy combined online with support (i.e.,
web-based health education) on inflammatory markers and
to verify possible correlations between energy-adjusted dietary
inflammatory index (E-DII) with inflammatory markers in obese

Obesity is a multifactorial disease that requires interdisciplinary
therapy and preventive strategies. Obesity-related comorbidities,
such as diabetes and cardiovascular disease, currently represent
the main costs incurred by health care systems (1, 2). The
prevalence of obesity in children and adolescents is increasing
worldwide. In Brazil, 20.5% of adolescents between 10 and 19
years old are overweight and 4.9% are obese (3, 4).
Obesity is not just a matter of aesthetics and body image.
It also decreases life expectancy and results in cancer,
cardiovascular diseases, hypertension, diabetes, steatosis,
characterizing metabolic syndrome; all together raising mortality
risks (2, 5–7).
Adipose tissue releases adipokines that have specific functions,
among them; adiponectin may attenuate inflammatory response
and results in beneficial effects on cardiovascular disorders.
However, studies indicate that obese individuals present lower
concentrations of adiponectin, and concomitantly they are in a
state of hyperleptinemia, favoring inflammation. The change in
homeostasis and release of cytokines, characterize obesity as a
condition of persistent low-grade inflammation, which is closely
associated with obesity-related comorbidities (8–11).
Leptin is one of the main factors involved in the energy
balance regulation. Obese patients show leptin-resistance that, in
turn, can favor inflammatory state (12). In fact, leptin resistance
in obese adolescents could influence an expansion of adipose
tissue by increasing the release of leptin to supply the resistance,
thus leading to problems with weight loss, and contributing
to inflammation (13). Therefore, the adiponectin/leptin ratio is
an interesting and pertinent indicator relating to adipose tissue
dysfunction (14).
While food intake and eating habits are key factors for
the promotion of health and prevention of weight gain and
cardiovascular disease, some specific dietary components may
modulate the inflammation and oxidative stress in obese
individuals. Indeed, several studies have observed associations
between inflammatory diets and comorbidities, such as obesity,
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FIGURE 1 | Study design.

participate in an interdisciplinary weight loss program. The study
was developed in accordance with the Declaration of Helsinki
and was approved by the Federal University to Sao Paulo ethics
committee (#0448/2018). Brazilian Clinical Trial registration
number: RBR-6txv3v. The Figure 1 shows the study design.

adolescents. We hypothesized that the therapy will improve body
composition and inflammatory biomarkers, and that reduction
of inflammatory biomarkers is correlated with changes in E-DII.

MATERIALS AND METHODS

Anthropometric Measurements and
Body Composition

Population
Forty-five pubertal obese adolescents (21 boys, 24 girls) were
enrolled in this study. The study was announced in the media
(journals, magazines, radio, and TV) and the adolescents were
selected according to the inclusion and exclusion criteria. The
inclusion criteria were a body mass index (BMI) p > 95th
percentile (40); age between 14 and 19 years and post-pubertal
Tanner Stage ≥V (41). Exclusion criteria were cardiovascular
disease, musculoskeletal problems that limited physical exercise,
autoimmune diseases, genetic, metabolic or endocrine disease
and chronic alcohol consumption and tabaco consumption
and also who used drugs/medicaments and/or nutritional
supplements that alter the metabolism during the last 6 months,
and who did not have access to electronic means. Predicting a
dropout of ∼20%, 57 adolescents started the interdisciplinary
therapy and 45 adolescents completed the intervention. The main
reasons for the treatment dropout were job opportunities and
school, followed by financial and family problems.
At initial interview the protocol was shared with the
volunteers, who had received a parental consent form to

Frontiers in Nutrition | www.frontiersin.org

Body weight was measured using light clothes and barefoot
on a Filizola R scale to 0.1 kg and capacity of 180 kg. Height
was measured using to a wall-mounted height board (Sanny R )
to the nearest 0.1 cm. Body mass index was then calculated
as body weight (kg)/height (meter)². Waist circumference and
abdominal circumference were measured with a flexible and
inelastic tape. Body composition was measured by a Bioimpedance meter (BIA) and the basal metabolic rate was
estimate based on body composition provide by the device
BIODYNAMICS 310e (TBW R ), that has accuracy: Correlation
of R = 0.98 with Hydrostatic Weighing and accuracy of ± 1% in
Resistance reading.

Serum Analysis
Blood samples were collected after an overnight 12-h fast. Plasma
insulin concentration was measured by radioimmunoassay.
According to Schwimmer et al. (42), normal plasma levels
of fasting insulin are lower than 17 uU/ml. Plasma glucose

3

June 2019 | Volume 6 | Article 77

Ferreira et al.

Inflammatory Diet, Obesity and Cardiometabolic Parameters

was measured by an enzymatic method with a UV-Visible
spectrophotometer and interpreted according to the established
criteria by the American Diabetes Association (43). Total
cholesterol, cholesterol fractions and triglycerides (TG) were
analyzed using colorimetric comparative method. The cut-off
limits for total cholesterol, LDL-c, HDL-c, and triglycerides were
established according to the Brazilian Society of Cardiology
(2013) (44). Insulin resistance (HOMA-IR) and insulin sensitivity
(QUICKI) were estimated by evaluation model obtained using
the formulas proposed by Matthews et al. (45) and Katz et al.
(46), respectively:
HOMA-IR: Insulin fasted (Uµ/ml) x fasted blood
glucose (mmol/ml)/22.5
QUICKI: 1/(log fasting insulin (Uµ/ml) + log fasting
glycaemia (mg/dl)
Adiponectin and Leptin were measured with enzyme-linked
immunosorbent assay (ELISA) kit from R&D Systems
(Minneapolis, MN, USA).

FIGURE 2 | Correlation between 1 E-DII and 1 Body fat mass of adolescents
who increased the energy adjusted DII.

Interdisciplinary Therapy Associated With
Web-Based Educational Health Approach

Nutritional Therapy

Endocrinologists, nutritionists, psychologists, and exercise
physiologists developed the interdisciplinary weight loss therapy.
In the present investigation, the volunteers completed five
face-to-face meetings, including individual and group sessions
and during 20-weeks intervention they had access to videos with
health topics based on e-book: Saber Emagrecer Dâmaso (47).
Weekly, body weight was monitored by self-report and photo of
their scales. The researchers advised that body weight should be
measured on the same equipment to avoid variability among the
equipment. Applications related to android mobiles were used
to assist in the monitoring of physical exercise and nutritional
prescription. Participants also were contacted by phone or email
every week in order to motivate them and eventually answer
their questions during the intervention period.

Different themes were discussed in personal sessions and
online program weekly, including: food labels, diet and light
foods, weight loss diets, good food choices on weekends, and
celebrations. No supplements were recommended.
Daily energy intake was assessed using self-reported 24-h food
recalls (24 HR) completed at baseline and at the end of the 20week intervention. Hypocaloric diet was prescribed according to
age and gender, reducing caloric intake between 300 and 500
kcal/day, respecting the distribution of macronutrients proposed
by the Institute of Medicine (50). The DIETSMART R program
was used to analyze dietary intake and calculate nutrients intake
to calculate the E-DII per 4,184 kJ (1,000 kcal) of food consumed
(51). Lower values indicate an anti-inflammatory diet and
higher values represent pro-inflammatory diet (24). Twenty -four
nutrients were used to calculate the E-DII score (Carbohydrate,
Protein, Fat, Fiber, Cholesterol, saturated fat, mono-unsaturated
fat, poly-unsaturated fat, Omega3, Omega6, Niacin, Thiamin,
Riboflavin Vitamins (A, B12, B6, C, D, E), Iron, Magnesium, Zinc,
Selenium, Folic Acid, and Beta-carotene.

Clinical Therapy
Obese adolescents visited the endocrinologist at the beginning
and after therapy to address the health and clinical parameters,
including family history.

Psychological Therapy

Statistical Analysis

Once a month, the psychologist discussed important themes
about obesity, including, bulimia, anorexia, self-esteem, and
anxiety in groups.

Statistical analysis was performed using the program
STATISTICA version 7.0 for Windows. The accepted significant
value was α <5%. Data normality was verified with the
Kolmogorov-Smirnov test. Parametric data were expressed as
mean ± SD, and non-parametric data was normalized using
Z-scores. To analyze the effects of intervention and difference
between the groups according to the E-DII response: increased
the E-DII or decreased E-DII, ANOVA for repeated measures
(ANOVA two-way) followed by Fischer post hoc test were used.
Delta values (1) were used for the statistical analysis obtained
from the difference between the after therapy and baseline values
for each variable: 1 variable = after therapy value–baseline
value. Comparison of the delta values between the groups was

Exercise-Training
The physical activity level was monitored at the initial evaluation
and every 5 weeks by the International Physical Activity
Questionnaire (IPAQ)—short version (48). A self-guided method
was applied, in which the adolescents chose exercises related to
personal pleasure (49). In all face-to-face meetings a professional
guided the adolescent to do exercise at least 3 times/week and
duration of 1 h/session. Every week mobile apps were used to
monitor the physical exercise.

Frontiers in Nutrition | www.frontiersin.org
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0.96
BMI (Body Mass Index), BMR (Basal Metabolic Rate); a statistic difference between baseline and after therapy of obese adolescents (p < 0.05); c statistic difference between the groups in the end of therapy.

0.26
2009.77 ± 293.75
2053.77 ± 320.75
2040.65 ± 335.11
2096.43 ± 330.30
2025.56 ± 312.38a
2075.58 ± 322.67
BMR (kcal)

0.94

0.94

0.23

0.23

66.11 ± 9.66a

65.53 ± 5.27a,c

67.35 ± 10.71

63.12 ± 4.95
62.24 ± 4.45

67.13 ± 11.04a
68.95 ± 10.86

61.59 ± 5.27

66.63 ± 10.28a
68.17 ± 10.70

62.34 ± 5.12

Fat free mass (kg)

Fat free mass (%)

63.85 ± 5.09

0.94

0.99
0.45

0.23
34.46 ± 5.27a,c

34.73 ± 6.58a,c
39.90 ± 7.97

36.88 ± 4.96
37.75 ± 4.45

40.53 ± 8.40a

38.40 ± 5.27

43.33 ± 9.36

36.14 ± 5.09a

37.70 ± 8.04a

37.66 ± 5.12

41.65 ± 8.78

Body fat mass (%)

Body fat mass (kg)

0.99

0.99
0.41

0.51
38.37 ± 2.81a

118.45 ± 8.08a
122.35 ± 9.24

40.00 ± 3.45
38.23 ± 4.06a

123.32 ± 8.28a

39.40 ± 4.03

127.46 ± 8.80

38.3 ± 3.47a

120.94 ± 8.46a

39.69 ± 3.73

124.96 ± 9.29

Neck circumference (cm)

119.20 ± 9.66
110.44 ± 18.00a

Hip circumference (cm)

0.92

0.99
0.41

0.22
106.75 ± 23.68a
117.14 ± 11.92

110.79 ± 10.71
105.18 ± 10.86a

113.98 ± 9.31

103.51 ± 10.58ca
108.79 ± 10.43

39.24 ± 4.73

106.77 ± 11.14a

0.99
0.59

0.63
34.37 ± 4.30a,c
36.83 ± 4.34

100.86 ± 12.16a
107.24 ± 14.41
107.57 ± 16.9a
112.29 ± 16.94

35.91 ± 4.72a

After therapy
Baseline
After therapy
Baseline

104.29 ± 15.05a

118.19 ± 10.75

According to the deltas analysis it was observed that body
fat mass and QUICKI were statistically different between
adolescents who increased DII and decreased DII after therapy.
No differences were observed in the deltas of adipokines
(Table 4).

Abdominal circumference (cm)

Comparison the Effects of Therapy
Between the Groups

109.81 ± 10.50

The adolescents had significant decrease in energy intake after
therapy, as well as reductions in dietary carbohydrate, lipids, and
sodium intake. The glycemic load of the diet decreased (Table 3).

Waist Circumference (cm)

Effects of Therapy on Diet Patterns

109.82 ± 15.78

The leptin decreased significantly after the intervention,
while adiponectin/leptin ratio increased in all adolescents. At
baseline, the leptin concentration was statistically different
between adolescents who increased and decreased the energyadjusted dietary inflammatory index (Table 2). Adolescents
who decreased the E-DII reduced leptin and increase the
adiponectin/leptin ratio after the therapy.

Body weight (kg)

Effects of Therapy on Adipokines

Baseline

TABLE 1 | Anthropometric measurements and body composition before and after therapy.

Considering the biochemical parameters, only HDL-C was
shown to significantly increase (p < 0.05) while all the
other metabolic parameters remained unchanged. On
the other hand, the subgroup with decreased E-DII had
increase in QUICKI and reduction in glycaemia, VLDLc, triglycerides, and HOMA-IR. The therapy was effective
in increasing the HDL-c even in the group that increased
the E-DII.

variables

Effects of Therapy on
Biochemical Parameters

All (n = 45)

Increased E-DII (n = 23)

The study population consisted of 45 adolescents.
Assessment of anthropometric measurements and body
composition at the beginning and after therapy are
presented. The therapy was effective in reducing body
weight, BMI, waist circumference, neck circumference,
hip circumference and body fat mass (% and kg;
Table 1).
The subgroup of individuals that decreased E-DII showed
significantly greater decrease in BMI, body fat mass (kg and %)
and increase in fat free mass (%) after therapy. The BMI, body
weight (kg), waist circumference, neck and hip circumference
decreased in both groups (Table 1).

After therapy

Decreased E-DII (n = 22)

Effects of Therapy in Anthropometric
Measurements and Body Composition

38.06 ± 4.66

Effect
size

RESULTS

BMI (Kg/m²)

Observed
power

performed by t-test independent by groups. Product moment;
i.e., Pearson correlation coefficients were computed.
Using the G∗ Power R 3.0.10 program, it was obtained a sample
size of 46 voluntaries, considering the statistical analysis realized
by ANOVA for repeated measures (ANOVA two-way). The effect
size 0.30, power 80%, based on E-DII and two groups and two
times of evaluation (baseline and after 20 weeks of intervention).

0.99

Inflammatory Diet, Obesity and Cardiometabolic Parameters

37.39 ± 4.72a
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variables

All (n = 45)

Baseline
Glycemia (mg/dL)
Total Cholesterol (mg/dL)
HDL-C (mg/dL)
Non-HDL (mg/dL)

After therapy

Increased E-DII (n = 23)

Baseline

After therapy

Decreased E-DII (n = 22)

Baseline

Effect
size

Observed
power

0.21

After therapy

90.53 ± 7.83

88.73 ± 7.51

91.26 ± 9.21

91.04 ± 6.71

89.77 ± 6.20

86.32 ± 7.67c

0.03

164.53 ± 34.58

160.98 ± 38.97

160.78 ± 39.93

165.22 ± 43.00

168.45 ± 28.34

156.55 ± 34.70

0.009

0.09

40.51 ± 8.43

43.80 ± 8.58a

41.52 ± 9.37

45.48 ± 9.29a

39.45 ± 7.39

42.05 ± 7.58

0.23

0.94
0.40

124.02 ± 31.66

113.80 ± 36.41

119.39 ± 35.40

113.13 ± 38.84

128.86 ± 27.18

114.50 ± 34.59

0.06

LDL-c (mg/dL)

99.51 ± 31.36

93.80 ± 32.91

92.74 ± 33.81

92.35 ± 37.76

106.59 ± 27.57

95.32 ± 27.77

0.03

0.21

VLDL-c (mg/dL)

24.44 ± 9.18

22.38 ± 10.92

26.52 ± 10.50

25.43 ± 10.58

22.27 ± 7.17

19.18 ± 10.57c

0.03

0.25

121.96 ± 45.76

111.67 ± 54.33

132.57 ± 52.38

126.65 ± 52.88

110.86 ± 35.50

96.00 ± 52.45c

0.03

0.25

20.02 ± 12.43

17.83 ± 13.03

21.65 ± 16.16

21.45 ± 16.44

18.31 ± 6.66

14.04 ± 6.59

0.03

0.24

HOMA-IR

4.51 ± 2.84

3.98 ± 3.04

4.90 ± 3.66

4.86 ± 3.80

4.10 ± 1.58

3.06 ± 1.59c

0.03

0.2

QUICKI

0.31 ± 0.02

0.32 ± 0.03

0.31 ± 0.03

0.31 ± 0.02

0.31 ± 0.02

0.33 ± 0.03a,c

0.08

0.51

TG (mg/dL)
Insulin (Uµ/mL)

Adiponectin (µg/mL)
Leptin (ng/mL)
Adipo/lep

Ferreira et al.
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TABLE 2 | Biochemical parameters and adipokines of obese adolescents before and after therapy.

2.67 ± 2.06

3.64 ± 3.27

2.51 ± 1.53

3.90 ± 3.74

2.83 ± 2.52

3.36 ± 2.75

0.08

0.47

63.74 ± 41.37

49.80 ± 41.38a

75.78 ± 47.96

62.49 ± 48.89

51.17 ± 29.20b

36.54 ± 26.88c

0.23

0.94

0.06 ± 0.05

0.13 ± 0.18a

0.05 ± 0.05

0.11 ± 0.12

0.06 ± 0.04

0.16 ± 0.22a

0.18

0.86

6

HDL-c, High-density lipoprotein cholesterol; LDL-c, Low-density lipoprotein cholesterol; VLDL-c, very low-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment insulin resistance; QUICKI, quantitative insulin-sensitivity
check index. adipo/lep: adiponectin/leptin ratio;
Data are presented as mean (SD);
a statistic difference between baseline and after therapy of obese adolescents (p < 0.05);
b statistic difference between baseline of adolescents (p < 0.05);
c statistic difference between the groups in the end of therapy.
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variables

All (n = 45)

Baseline

Increased E-DII (n = 23)

After therapy

Baseline

After therapy

Decreased E-DII (n = 22)

Baseline

Effect
size

Observed
power

After therapy

1965.49 ± 830.70

1491.40 ± 623.8a

1894.09 ± 901.66

1532.70 ± 639.21

2040.14 ± 763.37

1448.23 ± 619.22a

0.21

0.92

251.92 ± 106.14

181.06 ± 67.14a

245.10 ± 120.69

180.88 ± 48.26a

259.39 ± 89.94

181.25 ± 83.69a

0.24

0.95

Protein (g)

97.11 ± 51.29

81.24 ± 57.8

94.36 ± 49.90

90.36 ± 76.14

99.99 ± 53.72

71.70 ± 27.22

0.04

0.31

Fat (g)

25.95 ± 45.70

14.22 ± 10.17a

60.37 ± 32.78

50.46 ± 44.21

70.14 ± 31.29

49.28 ± 33.93a

0.14

0.76

Saturated Fat (g)

30.12 ± 50.24

12.92 ± 8.16

16.87 ± 11.87

15.55 ± 10.01

35.46 ± 63.59

12.83 ± 10.40a

0.06

0.39

8.70 ± 5.86

6.31 ± 5.87

8.58 ± 6.43

5.86 ± 3.69

0.09

0.53

23.03 ± 13.90

15.16 ± 8.00a

16.18 ± 12.18

16.99 ± 8.07

0.04

0.30

Energy Intake (kcal)
Carbohydrate (g)

Polyunsaturated fat (g)
Fiber (g)
Dietary Cholesterol (mg)

8.64 ± 6.08
19.68 ± 13.4

6.09 ± 4.87a
16.05 ± 7.99

287.18 ± 184.41

236.5 ± 185.32

270.87 ± 181.17

263.88 ± 209.76

304.23 ± 190.45

207.87 ± 155.51

0.05

0.32

4172.73 ± 3491.2

2634.38 ± 2264.83a

4389.47 ± 3824.32

3205.96 ± 2690.59

4150.68 ± 3191.44

2036.83 ± 1559.32a

0.22

0.93

1.16 ± 1.52

0.83 ± 1.49

0.24 ± 1.19

1.57 ± 1.31a

2.21 ± 1.20

0.11

0.66

Glycemic Load

82.58 ± 51.36

59.82 ± 35.72a

84.13 ± 56.98

58.52 ± 29.76a

80.95 ± 46.06

Vitamin C (mg)

102.10 ± 106.84

112.68 ± 177.30

135.91 ± 112.90

54.59 ± 47.03a

66.75 ± 89.45

Sodium (mg)
E-DII

Vitamin E (mg)
Folate (mcg)
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TABLE 3 | Energy intake, macronutrients, micronutrients, fiber dietary, and DII before and after therapy.

0.06 ± 1.27a,c
61.18 ± 41.74
173.42 ± 236.61a,c

0.13

0.70

0.04

0.07

10.25 ± 7.74

6.91 ± 6.72a

10.98 ± 7.83

5.84 ± 5.55a

9.49 ± 7.76

8.03 ± 7.73

0.10

0.57

148.64 ± 92.25

108.66 ± 68.03a

171.58 ± 93.19

84.57 ± 42.83a

124.65 ± 133.85

133.85 ± 80.47c

0.12

0.67

7

E-DII, Energy- adjusted Dietary Inflammatory Index; a -P <0.05;
a statistic difference between baseline and after therapy of obese adolescents (p < 0.05);
b statistic difference between baseline of adolescents (p < 0.05c ) statistic difference between adolescents in the end of therapy;
c statistic difference between the groups in the end of therapy.
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TABLE 4 | Delta values of the parameters analyzed.
All
(n = 45)

E-DII increased
(n = 23)

E-DII decreased
(n = 22)

Body weight (kg)

−5.53 ± 4.72

−4.72 ± 4.46

−6.38 ± 4.93

BMI (kg/m²)

−2.15 ± 1.68

−1.85 ± 1.75

−2.46 ± 1.59

Waist Circumference (cm)

−4.64 ± 5.56

−4.02 ± 3.00

−5.28 ± 7.39

Abdominal circumference (cm)

−7.75 ± 15.05

−5.22 ± 5.05

−10.40 ± 20.82

Neck circumference (cm)

−1.39 ± 1.40

−1.17 ± 0.95

−1.63 ± 1.76

Hip circumference (cm)

−4.02 ± 4.84

−4.14 ± 3.49

−3.90 ± 6.02

Body fat mass (%)

−1.51 ± 2.94

−0.65 ± 3.08

−2.41 ± 2.54d

Body fat mass (kg)

−3.96 ± 4.60

−2.80 ± 4.57

−5.16 ± 4.43

Body fat mass (%)

−22.75 ± 58.67

−25.60 ± 65.80

−19.77 ± 51.55d

Fat free mass (kg)

−1.54 ± 2.77

−1.82 ± 3.02

−1.24 ± 2.53

−50.02 ± 85.18

−55.78 ± 92.73

−44.00 ± 78.22

Glycemia (mg/dL)

−1.80 ± 10.41

−0.22 ± 10.79

Total Cholesterol (mg/dL)

−3.56 ± 39.15

4.43 ± 40.45

BMR (kcal)

HDL-C (mg/dL)
Non-HDL (mg/dL)

3.29 ± 6.03

3.96 ± 6.28

−10.22 ± 39.29

−3.45 ± 9.98
−11.91 ± 36.79
2.59 ± 5.81

−6.26 ± 44.17

−14.36 ± 34.00
−11.27 ± 32.76

LDL-c (mg/dL)

−5.71 ± 32.68

−0.39 ± 32.42

VLDL-c (mg/dL)

−2.07 ± 10.48

−1.09 ± 11.85

−3.09 ± 8.99

−10.29 ± 51.74

−5.91 ± 58.48

−14.86 ± 44.53

−2.19 ± 11.69

−0.20 ± 15.02

−4.27 ± 6.40

-0.53 ± 2.88

−0.04 ± 3.67

4.10 ± 1.58

0.97 ± 3.31

1.39 ± 3.95

0.52 ± 2.48

TG (mg/dL)
Insulin (U/dL)
HOMA-IR
Adiponectin (µg/mL)
Leptin (ng/mL)

−13.94 ± 25.56

adipo/lep
Energy Intake (kcal)

−13.29 ± 30.35

0.07 ± 0.16

0.05 ± 0.10

−14.63 ± 20.06
0.10 ± 0.21

−474.09 ± 915.54

−361.39 ± 981.69

−591.91 ± 847.47

Carbohydrate (g)

−65.26 ± 123.89

−64.22 ± 126.35

−66.34 ± 124.22

Protein (g)

−15.88 ± 72.25

−4.00 ± 89.68

−28.29 ± 46.87

-15.26 ± 37.55

−9.90 ± 37.52

−20.85 ± 37.62

Fat (g)

−11.74 ± 46.86

−1.32 ± 15.11

−22.63 ± 64.17

Polyunsaturated fat (g)

Saturated Fat (g)

−2.55 ± 8.13

−2.39 ± 8.90

−2.72 ± 7.44

Fiber (g)

−3.63 ± 16.27

−7.86 ± 16.07

−50.68 ± 225.22

−6.99 ± 240.15

Dietary Cholesterol (mg)
Sodium (mg)

−1638.35 ± 3131.78

E-DII
Glycemic Load

−1183.51 ± 3312.24

0.41 ± 1.96

1.33 ± 0.89

−22.76 ± 58.67

0.81 ± 15.62
−96.36 ± 203.94
−2113.85 ± 2931.45
−2.07 ± 1.23d

−25.60 ± 65.80

−19.77 ± 51.55

−81.32 ± 95.17

106.67 ± 248.91d

Vitamin C (mg)

10.58 ± 207.68

Vitamin E (mg)

−3.34 ± 10.12

−5.14 ± 8.84

−1.46 ± 11.20

−39.98 ± 115.29

−87.01 ± 91.65

133.85 ± 80.47d

Folate (mcg)

BMI (Body Mass Index), BMR (Basal Metabolic Rate); HDL-c, High-density lipoprotein cholesterol; LDL-c, Low-density lipoprotein cholesterol; VLDL-c, very low-density lipoprotein
cholesterol; HOMA-IR, homeostasis model assessment insulin resistance; QUICKI, quantitative insulin-sensitivity check index; adipo/lep, adiponectin/leptin ratio;
d Difference statistic between delta (1) of DII increased and DII decreased.

DISCUSSION

For the components of dietary intake and EDII, the deltas of Vitamin C, E, folate, and E-DII
are
statically
different
between
adolescents
that
increased and decreased E-DII after the therapy
(Table 4).

The present study indicates that long-term interdisciplinary
therapy coupled with web-based health education can contribute
to reducing obesity and associated inflammatory processes.
Indeed, the E-DII can be used to ameliorate health conditions in
adolescents with obesity. In fact, we consider E-DII relevant from
a clinical point of view to improve biochemical parameters and
inflammation parameters (leptin and adiponectin), as well as to
help to attenuate cardiovascular risks. The present investigation
indicates that adolescents who observed the dietary advice tended

Correlations Between Variables
A negative correlation was found between 1 EDII and 1 Body fat mass (%) (−0.68; p = 0.01)
in the group of adolescents who increased the
E-DII (Figure 2).
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to have lower E-DII scores, and improvements in anthropometric
and inflammatory parameters compared to their counterparts
who continue to eat pro-inflammatory diet.
Previous studies showed that dietary pattern and obesity could
induce inflammation and increase the risk for type 2 diabetes,
cardiovascular disease, and metabolic syndrome (52–54). In
the present investigation, we analyzed the possible relations
between the E-DII score and cardiometabolic parameters in
obese adolescents.
It was found an improvement in QUICKI after therapy
occurred only in adolescents who decreased the E-DII, when
the sample was analyzed according the E-DII response. QUICKI
is a reliable index of insulin sensitivity (44). This same
group decreased glycemia, VLDL-c, triglyceride, and HOMAIR. As previously demonstrated, insulin resistance is related to
inflammatory processes, increasing risk of cardiovascular disease
in obese adolescents (36, 55). It is important to know that these
variables have been related to cardiovascular risks and metabolic
syndrome, reinforcing the benefits of interdisciplinary therapy
for the management of obesity and its related comorbidities in
adolescents. Together, these results should be considered in the
clinical practices.
Moreover, the therapy was effective at improving HDLc concentrations. High level of HDL-c may contribute to
cardiometabolic protection, while low HDL-c correlates with
metabolic syndrome in obese adolescent (56, 57).
Additionally, the present study showed negative correlation
between 1 E-DII and 1 body fat mass (%) in the group
who increased the inflammatory diet profile, contributing to
our understood to the importance of this E-DII in the clinical
practice, as adjuvant in follow the patients to improve their
health conditions.
Importantly our results show a reduction in total caloric
intake as well as lower sodium, carbohydrate, and lipids intake
by the end of the intervention of all adolescents. High calorie diet
rich in lipids and micronutrients such as sodium can promote
an increase in inflammatory indices of diet. It is well known
that caloric intake higher than energy expenditure leads to
body weight gain and fat deposition and that sodium intake is
associated with metabolic disorders (58, 59).
Interesting, leptin is involved in the inflammatory process, and
the state of hyperleptinemia may limit the adiponectin increase
(9). Previous studies showed that adolescents undergoing
long-term multidisciplinary therapy had significant reduction
in leptin and increase in adiponectin concentration. These
results are in line with our findings suggesting an attenuated
inflammatory process after the proposed therapy. Although,
the interdisciplinary intervention had been able to reduce
hyperleptinemia state, children and adolescents should maintain
healthy lifestyle to reach normal levels of this hormone
(35, 60–63).
Hyperleptinemia was associated with hypoadiponectinemia,
contributing to increased related inflammatory process obese
adolescents (11, 35, 61, 64). Previous studies of this group showed
that changes in body mass and BMI are positively correlated
with decreased leptin concentration. It is important to note that
a significant decrease in leptin concentration is observed when
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the adolescents reduced their body mass by at least 7% (55).
Confirming our hypothesis, we found a decrease in the leptin
concentration and inversely an increase in adiponectin/leptin
ratio in all analyzed adolescents after the therapy.
Moreover, we found an increase in adiponectin/leptin ratio
and a decrease in leptin on the group of decreased E-DII.
This ratio could be an atherosclerotic risk maker (65) while
the adiponectin/leptin ratio could be a valuable complementary
element in prediction and prevention of cardiovascular diseases
and metabolic syndrome (66, 67), suggesting that our therapy was
effective to improve these parameters.
Other interesting results from this study include the reduction
of BMI and improved body composition. This corroborates a
systematic review with obese adolescents that pointed out that
a multicomponent therapy, including education health were
effective in improving body composition and cardiometabolic
biomarkers (68, 69).
Additionally, the interdisciplinary therapy was effective in
reducing waist, neck, hip, and abdominal circumferences. These
circumferences are positively correlated with cardiovascular
risks, obesity, and metabolic syndrome; and the improvement
of these anthropometric indicators are important in controlling
obesity and cardiovascular diseases (61, 67, 68, 70–74).
Faced with the above results and the improvement of
fat-free mass (%), it is extremely important for health
professionals to consider both the quantity and quality of
the adolescent’s diet as well as to encourage a change
to healthy eating and active lifestyles, early in life, to
prevent short-term and long-term morbidity and improve
cardiometabolic parameters.
Some limitations of the present study are the lack of
lean control group. Second, the Brazilian database is not
complete with the 45 food parameters to calculate the EDII, moreover these analyses were exploratory. However, our
study takes future directions to investigate the inflammatory
diet and the impact on metabolic and inflammatory process
of obesity.
In conclusion, the long-term interdisciplinary therapy
combined with web-based health education were effective in
improving inflammatory markers in adolescents with obesity. In
addition, these results showed that in exploratory analyses, an
improvement of inflammatory and cardiometabolic parameters
occurred mainly when the E-DII improved an increased
inflammatory profile diet, suggesting the relevance to stimulate
anti-inflammatory diet habits as an effective strategy to prevent
and treat obesity and related comorbidities in adolescents
with obesity.
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W. Serum adiponectin and leptin concentrations in relation to body fat
distribution, hematological indices and lipid profile in humans. Int J Environ
Res Public Health. (2015) 12:11528–48. doi: 10.3390/ijerph120911528
67. Vega GL, Grundy SM. Metabolic risk susceptibility in men
is partially related to adiponectin/leptin ratio. J Obes. (2013)
2013:409679. doi: 10.1155/2013/409679
68. Rajjo T, Mohammed K, Alsawas M, Ahmed AT, Farah W, Asi N, et al.
Treatment of pediatric obesity: an umbrella systematic review. J Clin
Endocrinol Metab. (2017) 102:763–75. doi: 10.1210/jc.2016-2574
69. Mameli C, Krakauer JC, Krakauer NY, Bosetti A, Ferrari CM, Schneider L,
et al. Effects of a multidisciplinary weight loss intervention in overweight and
obese children and adolescents: 11 years of experience. PLoS ONE. (2017)
12:e0181095. doi: 10.1371/journal.pone.0181095

32. Shivappa N, Hebert JR, Neshatbini Tehrani A, Bayzai B, Naja F, Rashidkhani
B. A pro-inflammatory diet is associated with an increased odds of depression
symptoms among iranian female adolescents: a cross-sectional study. Front
Psychiatry. (2018) 29:400. doi: 10.3389/fpsyt.2018.00400
33. Rocha NP, Milagres LC, Longo GZ, Ribeiro AQ, Novaes JF.
Association between dietary pattern and cardiometabolic risk in
children and adolescents: a systematic review. J Pediatr. (2017)
93:214–22. doi: 10.1016/j.jped.2017.01.002
34. Silva DFO, Lyra CO, Lima SCVC. Dietary habits of adolescents and associated
cardiovascular risk factors: a systematic review. Ciênc Saúde Coletiva. (2016)
21:1181–96. doi: 10.1590/1413-81232015214.08742015
35. Masquio DC, de Piano A, Campos RM, Sanches PL, Carnier J, Corgosinho
FC, et al. The role of multicomponent therapy in the metabolic syndrome,
inflammation and cardiovascular risk in obese adolescents. Br J Nutr. (2015)
113:1920–30. doi: 10.1017/S0007114515001129
36. de Sanches PL, Mello MT, Fonseca FA, Elias N, Piano AD, Carnier
J, et al. Insulin resistance can impair reduction on carotid intimamedia thickness in obese adolescents. Arq Bras Cardiol. (2012) 99:892–8.
doi: 10.1590/S0066-782X2012005000077
37. Julian V, Thivel D, Pereira B, Costes F, Richard R, Duclos M. Improving
peripheral and central vascular adjustments during exercise through a
training program in adolescents with obesity. Obes Facts. (2016) 9:321–31.
doi: 10.1159/000447456
38. Lopera CA, da Silva DF, Bianchini JA, Locateli JC, Moreira AC, Dada RP,
et al. Effect of water- versus land-based exercise training as a component of a
multidisciplinary intervention program for overweight and obese adolescents.
Physiol Behav. (2016) 165:365–73. doi: 10.1016/j.physbeh.2016.08.019
39. Almeida SS, Corgosinho FC, Amorim CE, Gregnani MF, Campos
RM, Masquio DC, et al. Different metabolic responses induced by
long-term interdisciplinary therapy in obese adolescents related to
ACE I/D polymorphism. J Renin Angiotensin Aldosterone Syst. (2017)
18:2. doi: 10.1177/1470320317703451
40. de Onis, M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann
J. Development of a WHO growth reference for school-aged
children and adolescents. Bull World Health Organ. (2007) 85:660–7.
doi: 10.2471/BLT.07.043497
41. Tanner JM, Whitehouse RH. Clinical longitudinal standards for height,
weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child.
(1976) 51:170–9.
42. Schwimmer, JB, Deutsch R, Rauch JB, Behling C, Newbury R, Lavine
JE. Obesity, insulin resistance, and other clinicopathological correlates
of pediatric nonalcoholic fatty liver disease. J Pediatr. (2003) 143:500–
5. doi: 10.1067/S0022-3476(03)00325-1
43. American Diabetes Association. Diagnosis and classification of diabetes
mellitus. Diabetes Care. (2015) 38:S8–16. doi: 10.2337/dc15-S005
44. Xavier HT, Izar MC, Faria Neto JR, Assad MH, Rocha VZ, Sposito AC, et al.
V Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose. Arquivos
Brasil Cardiol. (2013) 101:1–20. doi: 10.5935/abc.2013S010
45. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner
RC. Homeostasis model assessment: insulin resistance and beta-cell function
from fasting plasma glucose and insulin concentrations in man. Diabetologia.
(1985) 28:412–9.
46. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al.
Quantitative insulin sensitivity check index: a simple, accurate method for
assessing insulin sensitivity in humans. J Clin Endocrinol Metab. (2000)
85:2402–10. doi: 10.1210/jcem.85.7.6661
47. Dâmaso AR. Saber Emagrecer. São Paulo: Weight Science (2015).
48. Matsudo S, Araújo T, Matsudo V, Andrade D, Andrade E, Oliveira LC, et al.
International physical activity questionnaire (IPAQ): study of validity and
reliability in Brazil. Rev Brasil Atividade Física Saúde. (2001) 6:5–18.
49. Pinto AM, Gorin AA, Raynor HA, Tate DF, Fava JL, Wing RR. Successful
weight-loss maintenance in relation to method of weight loss. Obesity.
(2008) 16:2456–61. doi: 10.1038/oby.2008.364
50. Institute of Medicine (US) Subcommittee on Interpretation and Uses of
Dietary Reference Intakes, Institute of Medicine (US) Standing Committee on
the Scientific Evaluation of Dietary Reference Intakes. DRI Dietary Reference
Intakes: Applications in Dietary Assessment. Washington, DC: National
Academies Press (US) (2000).

Frontiers in Nutrition | www.frontiersin.org

11

June 2019 | Volume 6 | Article 77

Ferreira et al.

Inflammatory Diet, Obesity and Cardiometabolic Parameters

Conflict of Interest Statement: JH owns controlling interest in Connecting
Health Innovations LLC (CHI), a company that has licensed the right to his
invention of the dietary inflammatory index (DII) from the University of South
Carolina in order to develop computer and smart phone applications for patient
counseling and dietary intervention in clinical settings. NS is an employee of CHI.

70. Patnaik L, Pattnaik S, Rao EV, Sahu T. Validating neck circumference and
waist circumference as anthropometric measures of overweight/obesity in
adolescents. Indian Pediatr. (2017) 54:377–80.
71. Masquio DC, Ganen Ade P, Campos RM, Sanches Pde L, Corgosinho
FC, Caranti D, et al. Cut-off values of waist circumference to predict
metabolic syndrome in obese adolescents. Nutr Hosp. (2015) 31:1540–
50. doi: 10.3305/nh.2015.31.4.8442
72. Mansour M, Nassef YE, Shady MA, Aziz AA, Malt HAE. Metabolic syndrome
and cardiovascular risk factors in obese adolescent. Open Access Macedonian
J Med Sci. (2016) 4:118–21. doi: 10.3889/oamjms.2016.037
73. Kurtoglu S, Hatipoglu N, Mazicioglu MM, Kondolot M. Neck circumference
as a novel parameter to determine metabolic risk factors in obese
children. Eur J Clin Invest. (2012) 42:623–30. doi: 10.1111/j.1365-2362.2011.
02627.x
74. Rajagopalan A, Balaji N. Association of neck circumference and
obesity with blood pressure among adolescents in urban and rural
population in North Tamil Nadu. J Nat Sci Biol Med. (2017) 8:144–9.
doi: 10.4103/jnsbm.JNSBM_29_17

Frontiers in Nutrition | www.frontiersin.org

The remaining authors declare that the research was conducted in the absence of
any commercial or financial relationships that could be construed as a potential
conflict of interest.
Copyright © 2019 Ferreira, Kravchychyn, Vicente, Campos, Tock, Oyama, Boldarine,
Masquio, Thivel, Shivappa, Hébert and Dâmaso. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.

12

June 2019 | Volume 6 | Article 77

